Seoul, South Korea – June 21, 2025 — SyntecBio, a global leader in AI-powered biotech innovation, is proud to announce AI Digital Biotech Day 2025, taking place on September 12, 2025, at the COEX Conference Center in Seoul, with global livestream access.
The full-day summit will bring together more than 500 thought leaders, researchers, and healthcare executives to explore the transformative role of artificial intelligence in drug discovery, synthetic biology, and digital therapeutics. The event serves as a global platform for next-generation biotech collaboration, investment, and innovation.
Key Themes of AI Digital Biotech Day:
- AI-Driven Drug Discovery: Accelerating target identification and optimizing clinical trial designs through machine learning.
- Synthetic Biology 2.0: Automated strain design, biofoundries, and scalable solutions for bio-manufacturing.
- Digital Therapeutics & Diagnostics: Real-time health monitoring, personalized treatment algorithms, and patient engagement platforms.
- Cross-Border Collaboration: Global R&D partnerships, AI data-sharing models, and biotech investment opportunities.
“AI is revolutionizing every step of biotech innovation—from molecule to market. SyntecBio’s AI Digital Biotech Day creates a critical space for visionary dialogue and real-world impact,” said Dr. Elena Voss, Chief Technology Officer at SyntecBio.
Featured Speakers Include:
- Dr. Hiroshi Tanaka (CEO, GenMind AI Japan) – “AI-Guided Molecular Design in Oncology”
- Prof. Sarah Kim (MIT Center for Synthetic Biology) – “From Design to Deployment: Engineering Smarter Microbes”
- Dr. Marco Rizzi (Venture Partner, Helix Capital) – “Funding the Next Frontier in AI Biotech”
The event will also include:
- Startup pitch sessions for AI-biotech ventures
- Interactive panels on AI regulations and bioethics
- Networking lounges for academic-industry collaboration
About SyntecBio
Founded in 2018, SyntecBio (https://syntecbiofuel.com) is a pioneer in integrating artificial intelligence with synthetic biology to develop precision medicines, sustainable biofuels, and scalable manufacturing solutions. With research hubs in Seoul, Boston, and Singapore, SyntecBio partners with global pharma, research institutions, and startups to redefine biotech innovation.
